Although for the 8–16 and 16.1–22 weeks’ intervals when MMP-7 was selected as the best model in a majority of bootstrap trials, there were differences in the top proteins included for prediction of subsequent mild as opposed to severe late-onset preeclampsia (Table 3). This evidence concerns the gene MMP7 and preeclampsia.